Victor V Lobanenkov

8PUBLICATIONS
18CO-AUTHORS
Architectural heritage and conservationHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 04, 2025
CTCF binding landscape is shaped by the epigenetic state of the N-terminal nucleosome in relation to CTCF motif orientation.

Md Tajmul, Dharmendra Nath Bhatt, Luminita Ruje

|Jan 31, 2024
BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites.

Elena M Pugacheva, Dharmendra Nath Bhatt, Samuel Rivero-Hinojosa

|Mar 29, 2023
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors.

Dmitri Loukinov, Amanda Laust Anderson, Mikayel Mkrtichyan

|Sep 30, 2022
Ectopic expression of meiotic cohesin generates chromosome instability in cancer cell line.

Abdelhalim Boukaba, Jian Liu, Carl Ward

|Jun 23, 2021
The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis.

Samuel Rivero-Hinojosa, Elena M Pugacheva, Sungyun Kang

|Jan 16, 2020
CTCF mediates chromatin looping via N-terminal domain-dependent cohesin retention.

Elena M Pugacheva, Naoki Kubo, Dmitri Loukinov

Pageof 2